https://www.selleckchem.com/pr....oducts/2-Methoxyestr
032, HR = 1.485), were patients-related independent risk factors for LRR. The 5-year LRR rates were 1.7, 3.5, and 15.0% for patients with zero, 1-2, and 3-4 risk factors (p 0.001). Risk Stratification based on age, T stage, ER/PR status and tumor location can stratify patients with pT1-2 N0 breast cancer into subgroups with different risk of LRR. PMRT might be suggested for patients with 3-4 risk factors. Risk Stratification based on age, T stage, ER/PR status and tumor location can stratify patients with pT1-2 N0
Like
Comment
Share
